UK markets closed
  • FTSE 100

    +26.32 (+0.37%)
  • FTSE 250

    +123.85 (+0.54%)
  • AIM

    +4.02 (+0.33%)

    +0.0063 (+0.53%)

    +0.0074 (+0.54%)

    -566.91 (-1.26%)
  • CMC Crypto 200

    +57.32 (+4.07%)
  • S&P 500

    +33.11 (+0.75%)
  • DOW

    +382.20 (+1.09%)

    +1.35 (+1.66%)

    -29.80 (-1.66%)
  • NIKKEI 225

    +517.70 (+1.81%)

    +368.37 (+1.48%)
  • DAX

    +124.64 (+0.81%)
  • CAC 40

    +42.31 (+0.63%)

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery

·5-min read

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

New York, Oct. 04, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery" -

Reasons to Purchase:
• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Where is the largest and fastest growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceuticals market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters:

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section gives the segmentation of the veterinary pharmaceuticals market by geography, by type of product, by animal type, by route of administration and by end use channel.
Market Characteristics – The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different products covered in the report and basic definitions.
Supply Chain – The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.
Product Analysis – The product analysis section of the report describes the leading products along with key features and differentiators for those products/services.
Customer Information – This chapters covers recent customer and service providers’ trends/preferences in the global veterinary pharmaceuticals market.
Trends And Strategies – This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Regulatory Landscape– The section briefs on the regulatory landscape of veterinary pharmaceuticals.
Impact Of COVID-19 – The section briefs on the impact of COVID-19 on the veterinary pharmaceuticals market.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025, 2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
Segmentation – This section contains the market values (2015-2025, 2030F) and analysis for different segments in the market.
Global Macro Comparison – The global veterinary pharmaceuticals market comparison with macro-economic factors gives the veterinary pharmaceuticals market size, percentage of GDP, and average veterinary pharmaceuticals market expenditure.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025, 2030F) market value and growth, and market share comparison by region.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025, 2030F) market value, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa), and five countries (China, India, Japan, the USA and the UK).
Competitive Landscape – This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Background – This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-2025, 2030F values, and regional analyses for the animal medicine market.
Opportunities And Strategies – This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: 1) By Type Of Pharamaceutical: Veterinary Parasiticides; Veterinary Vaccines; Veterinary Antibiotics; Other Veterinary Pharmaceuticals
2) By Animal Type: Livestock; Companion Animal
3) By Route Of Administration: Oral; Others
4) By End Use Channel: Veterinary Hospitals; Pharmacies and Drug stores; Veterinary Clinics
5) By Type Of Antibiotic: Tetracyclines; Penicillin; Macrolides; Sulphanomides; Aminoglycosides; Others
6) By Type Of Vaccine: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; Others

Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co., Inc.; Elanco Animal Health Incorporated; Ceva Santé Animale

Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting